Last 7 days
0.2%
Last 30 days
14.2%
Last 90 days
19.8%
Trailing 12 Months
-13.2%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
JNJ | 409.0B | 96.3B | -3.62% | -9.57% | 32.14 | 4.25 | 1.46% | -35.83% |
LLY | 398.5B | 27.7B | 2.58% | 47.15% | 70.08 | 14.39 | -5.56% | -7.22% |
MRK | 272.8B | 57.9B | -4.82% | 28.79% | 17.88 | 4.63 | 7.21% | -8.11% |
PFE | 230.9B | 93.0B | -0.23% | -25.99% | 7.36 | 2.3 | 0.56% | 16.36% |
BMY | 150.1B | 45.8B | -1.47% | -11.26% | 23.72 | 3.25 | -2.37% | 16.96% |
MID-CAP | ||||||||
PRGO | 5.0B | 4.6B | -12.00% | -16.92% | -35.25 | 1.11 | 8.46% | -29.07% |
RETA | 3.5B | 1.5M | -8.84% | 225.36% | -11.32 | 1.6K | -86.94% | -16.59% |
SMALL-CAP | ||||||||
SUPN | 1.8B | 668.5M | -9.91% | 19.28% | 34.95 | 2.72 | 11.17% | -29.04% |
TLRY | 1.6B | 596.3M | -7.75% | -62.41% | -0.89 | 2.66 | -3.41% | -3791.67% |
INVA | 866.9M | 271.5M | 14.22% | -13.24% | 3.94 | 3.19 | -31.50% | -40.28% |
CRON | 666.4M | 112.3M | -6.91% | -41.08% | -4.29 | 5.94 | 7.69% | 41.96% |
ACRS | 590.7M | 30.8M | -2.33% | -39.30% | -6.14 | 19.16 | 378.90% | -19.01% |
OCUL | 536.4M | 51.7M | 11.79% | 117.61% | -6.04 | 10.38 | 4.69% | -299.77% |
CGC | 401.1M | 478.9M | -31.81% | -82.48% | -0.13 | 0.84 | -31.50% | -634.70% |
ENDP | 94.1M | 2.2B | -43.99% | -88.43% | -0.03 | 0.04 | -25.47% | -292.77% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Revenue | -4.8% | 272 | 285 | 373 | 404 | 396 |
Operating Expenses | -144.6% | -59.81 | 134 | 113 | - | - |
S&GA Expenses | 20.8% | 77.00 | 64.00 | 49.00 | 24.00 | 17.00 |
R&D Expenses | 16.3% | 48.00 | 41.00 | 31.00 | 20.00 | 6.00 |
EBITDA | -27.7% | 319 | 441 | 275 | 392 | - |
EBITDA Margin | -5.4% | 1.12* | 1.18* | 0.68* | 0.99* | - |
Earnings Before Taxes | -1.2% | 283 | 287 | 408 | 245 | 361 |
EBT Margin | -8.0% | 1.01* | 1.09* | 0.61* | 0.91* | - |
Interest Expenses | 9.0% | 17.00 | 16.00 | 17.00 | 16.00 | 17.00 |
Net Income | -34.1% | 220 | 334 | 208 | 297 | - |
Net Income Margin | -13.8% | 0.77* | 0.90* | 0.51* | 0.75* | - |
Free Cahsflow | -30.7% | 202 | 291 | 372 | 378 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Assets | -8.3% | 1,130 | 1,231 | 1,328 | 1,138 | 1,107 |
Current Assets | -33.2% | 296 | 444 | 455 | 400 | 318 |
Cash Equivalents | -50.5% | 144 | 291 | 301 | 284 | 217 |
Inventory | -11.2% | 50.00 | 56.00 | 71.00 | - | - |
Net PPE | 5.9% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill | 4.6% | 28.00 | 27.00 | 16.00 | 6.00 | 6.00 |
Current Liabilities | -71.7% | 38.00 | 135 | 164 | 126 | 109 |
LT Debt, Non Current | 0.1% | 445 | 444 | 444 | 443 | 443 |
Shareholder's Equity | -0.8% | 561 | 566 | 641 | 565 | 552 |
Retained Earnings | 17.0% | -170 | -204 | -136 | -402 | -403 |
Additional Paid-In Capital | -3.4% | 1,125 | 1,164 | 1,171 | 1,184 | 1,183 |
Shares Outstanding | -4.9% | 66.00 | 69.00 | 70.00 | 70.00 | 70.00 |
Minority Interest | NaN% | - | - | 177 | 166 | - |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Cashflow From Operations | -35.9% | 129 | 202 | 291 | 372 | 378 |
Share Based Compensation | 8.8% | 8.00 | 7.00 | 7.00 | 3.00 | 3.00 |
Cashflow From Investing | 189.7% | 51.00 | -56.63 | -67.86 | -165 | -73.04 |
Cashflow From Financing | -355.0% | -252 | -55.57 | -57.63 | 34.00 | -370 |
Buy Backs | 479.1% | 49.00 | 9.00 | 0.00 | 0.00 | 0.00 |
73.1%
61.9%
39.6%
Y-axis is the maximum loss one would have experienced if Innoviva was unfortunately bought at previous high price.
2.3%
-2.5%
-1.7%
FIve years rolling returns for Innoviva.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-06-01 | MACQUARIE GROUP LTD | reduced | -90.89 | -765,000 | 64,000 | -% |
2023-05-26 | ProShare Advisors LLC | reduced | -11.81 | -52,413 | 156,195 | -% |
2023-05-25 | Brandywine Global Investment Management, LLC | sold off | -100 | -2,423,460 | - | -% |
2023-05-23 | ROYCE & ASSOCIATES LP | added | 18.17 | 4,375 | 1,320,980 | 0.01% |
2023-05-22 | EMC Capital Management | unchanged | - | -57,000 | 322,000 | 0.27% |
2023-05-22 | PUTNAM INVESTMENTS LLC | unchanged | - | -376,856 | 5,394,980 | 0.01% |
2023-05-22 | AMERIPRISE FINANCIAL INC | reduced | -0.12 | -501,375 | 2,795,620 | -% |
2023-05-22 | PUTNAM INVESTMENTS LLC | added | 20.14 | 1,330,760 | 67,592,000 | 0.11% |
2023-05-18 | JPMORGAN CHASE & CO | reduced | -10.62 | -1,073,000 | 3,374,000 | -% |
2023-05-18 | NEW YORK STATE COMMON RETIREMENT FUND | reduced | -6.73 | -602,000 | 2,289,000 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
May 15, 2023 | sarissa capital management lp | 10.54% | 6,904,000 | SC 13D/A | |
Feb 14, 2023 | putnam investments llc | 7.6% | 5,329,107 | SC 13G | |
Feb 13, 2023 | renaissance technologies llc | 6.06% | 4,229,607 | SC 13G/A | |
Feb 10, 2023 | blackrock inc. | 15.2% | 10,611,839 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 10.13% | 7,072,212 | SC 13G/A | |
Feb 02, 2023 | westfield capital management co lp | 5.88% | 4,106,136 | SC 13G/A | |
Jan 26, 2023 | blackrock inc. | 10.6% | 5,671,100 | SC 13G/A | |
Jan 20, 2023 | blackrock inc. | 10.6% | 5,671,100 | SC 13G | |
Jul 11, 2022 | vanguard group inc | 10.00% | 6,970,950 | SC 13G/A | |
Feb 11, 2022 | renaissance technologies llc | 7.62% | 5,295,133 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
May 30, 2023 | 4 | Insider Trading | |
May 24, 2023 | 4 | Insider Trading | |
May 24, 2023 | 4 | Insider Trading | |
May 24, 2023 | 4 | Insider Trading | |
May 24, 2023 | 4 | Insider Trading | |
May 24, 2023 | 4 | Insider Trading | |
May 24, 2023 | 4 | Insider Trading | |
May 24, 2023 | 8-K | Current Report | |
May 24, 2023 | 8-K | Current Report | |
May 23, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-05-30 | DENNER ALEXANDER J | bought | 1,560,650 | 13.0054 | 120,000 | - |
2023-05-26 | DENNER ALEXANDER J | bought | 393,729 | 13.1243 | 30,000 | - |
2023-05-25 | DENNER ALEXANDER J | bought | 654,330 | 13.0866 | 50,000 | - |
2023-05-22 | Srivastava Sapna | acquired | - | - | 16,495 | - |
2023-05-22 | DiPaolo Mark | acquired | - | - | 16,495 | - |
2023-05-22 | Schlesinger Sarah J. | acquired | - | - | 16,495 | - |
2023-05-22 | Birx Deborah | acquired | - | - | 16,495 | - |
2023-05-22 | Odysseas Kostas D | acquired | - | - | 16,495 | - |
2023-05-22 | Haimovitz Jules | acquired | - | - | 16,495 | - |
2023-05-19 | Zhen Marianne | sold (taxes) | -10,560 | 13.47 | -784 | chief accounting officer |
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2023 | Mar. 31, 2022 | |
Revenue: | ||
Total revenue | $ 76,372 | $ 90,059 |
Expenses: | ||
Selling, general and administrative | 19,735 | 6,492 |
Research and development | 12,588 | 5,838 |
Amortization of acquired intangible assets | 3,805 | 0 |
Loss on extinguishment of debt | 0 | 20,662 |
Changes in fair values of equity method investments, net | (15,817) | 11,950 |
Changes in fair values of other equity and long-term investments, net | 2,164 | (2,539) |
Interest and dividend income | (3,365) | (322) |
Interest expense | 4,427 | 3,010 |
Other expense, net | 1,346 | 250 |
Total expenses | 35,232 | 45,341 |
Income before income taxes | 41,140 | 44,718 |
Income tax expense, net | 6,275 | 6,860 |
Net income | 34,865 | 37,858 |
Net income attributable to noncontrolling interests | 0 | 22,085 |
Net income attributable to Innoviva stockholders | $ 34,865 | $ 15,773 |
Basic net income per share attributable to Innoviva stockholders | $ 0.51 | $ 0.23 |
Diluted net income per share attributable to Innoviva stockholders | $ 0.42 | $ 0.20 |
Shares used to compute Innoviva basic and diluted net income per share: | ||
Shares used to compute basic net income per share | 67,786 | 69,544 |
Shares used to compute diluted net income per share | 89,788 | 93,730 |
Royalty revenue | ||
Revenue: | ||
Total revenue | $ 56,858 | $ 90,059 |
Net product sales | ||
Revenue: | ||
Total revenue | 11,514 | 0 |
Expenses: | ||
Cost of products sold (inclusive of amortization of inventory fair value adjustments, excluding depreciation and amortization of intangible assets) | 8,749 | 0 |
License revenue | ||
Revenue: | ||
Total revenue | 8,000 | 0 |
License | ||
Expenses: | ||
Cost of license revenue | $ 1,600 | $ 0 |
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 144,049 | $ 291,049 |
Accounts receivable , net | 15,490 | 9,401 |
Receivables from collaboration arrangement | 60,314 | 54,672 |
Inventory | 49,653 | 55,897 |
Prepaid expenses | 24,119 | 29,559 |
Other current assets | 2,821 | 2,933 |
Total current assets | 296,446 | 443,511 |
Property and equipment, net | 180 | 170 |
Equity Method Investment | 54,971 | 39,154 |
Equity and long-term investments | 400,894 | 363,859 |
Capitalized fees paid, net | 94,151 | 97,607 |
Right-of-use assets | 2,973 | 3,265 |
Goodwill | 27,946 | 26,713 |
Intangible assets | 248,314 | 252,919 |
Other assets | 3,893 | 4,299 |
Total assets | 1,129,768 | 1,231,497 |
Current liabilities: | ||
Accounts payable | 5,933 | 2,939 |
Accrued personnel-related expenses | 4,223 | 8,022 |
Accrued interest payable | 833 | 4,359 |
Deferred revenue | 2,094 | 2,094 |
Convertible subordinated notes due 2023, net of issuance costs | 0 | 96,193 |
Income tax payable | 154 | 154 |
Other accrued liabilities | 24,900 | 21,207 |
Total current liabilities | 38,137 | 134,968 |
Long-term debt, net of discount and issuance costs | 444,692 | 444,180 |
Other long-term liabilities | 70,133 | 70,918 |
Deferred tax liabilities, net | 5,392 | 5,771 |
Income tax payable, long-term | 9,921 | 9,872 |
Commitments and contingencies (Note 12) | ||
Stockholders' equity: | ||
Preferred stock: $0.01 par value, 230 shares authorized, no shares issued and outstanding | 0 | 0 |
Common stock: $0.01 par value, 200,000 shares authorized, 65,824 and 69,188 issued and outstanding as of March 31, 2023 and December 31, 2022, respectively | 659 | 692 |
Treasury stock: at cost, 32,005 shares as of March 31, 2023 and December 31, 2022, respectively | (393,829) | (393,829) |
Additional paid-in capital | 1,124,709 | 1,163,836 |
Accumulated deficit | (170,046) | (204,911) |
Total stockholders' equity | 561,493 | 565,788 |
Total liabilities and stockholders' equity | $ 1,129,768 | $ 1,231,497 |